Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII.

Burgos PI, Alarcón GS, McGwin G Jr, Crews KQ, Reveille JD, Vilá LM.

Arthritis Rheum. 2009 Sep 15;61(9):1179-86. doi: 10.1002/art.24649.

2.
3.

Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort.

Andrade RM, Alarcón GS, Fernández M, Apte M, Vilá LM, Reveille JD; LUMINA Study Group.

Arthritis Rheum. 2007 Feb;56(2):622-30.

4.

A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE.

Fernández M, Alarcón GS, Calvo-Alén J, Andrade R, McGwin G Jr, Vilá LM, Reveille JD; LUMINA Study Group.

Arthritis Rheum. 2007 May 15;57(4):576-84.

5.

Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.

Alarcón GS, McGwin G Jr, Bartolucci AA, Roseman J, Lisse J, Fessler BJ, Bastian HM, Friedman AW, Reveille JD; LUMINA Study Group. Lupus in Minority Populations, Nature versus Nurture.

Arthritis Rheum. 2001 Dec;44(12):2797-806.

PMID:
11762940
6.

Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course.

Alarcón GS, McGwin G Jr, Uribe A, Friedman AW, Roseman JM, Fessler BJ, Bastian HM, Baethge BA, Vilá LM, Reveille JD.

Arthritis Rheum. 2004 Jun 15;51(3):465-74.

7.

Features associated with, and the impact of, hemolytic anemia in patients with systemic lupus erythematosus: LX, results from a multiethnic cohort.

Durán S, Apte M, Alarcón GS, Marion MC, Edberg JC, Kimberly RP, Zhang J, Langefeld CD, Vilá LM, Reveille JD; Lumina Study Group.

Arthritis Rheum. 2008 Sep 15;59(9):1332-40. doi: 10.1002/art.24020.

8.

Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXIX. Elevation of erythrocyte sedimentation rate is associated with disease activity and damage accrual.

Vilá LM, Alarcón GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD; LUMINA Study Group.

J Rheumatol. 2005 Nov;32(11):2150-5.

PMID:
16265693
9.

Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time.

Alarcón GS, Calvo-Alén J, McGwin G Jr, Uribe AG, Toloza SM, Roseman JM, Fernández M, Fessler BJ, Vilá LM, Ahn C, Tan FK, Reveille JD; LUMINA Study Group.

Ann Rheum Dis. 2006 Sep;65(9):1168-74. Erratum in: Ann Rheum Dis. 2008 Nov;67(11):1652..

10.

The impact of increased body mass index on systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA XLVI) [corrected].

Chaiamnuay S, Bertoli AM, Fernández M, Apte M, Vilá LM, Reveille JD, Alarcón GS; LUMINA Study Group.

J Clin Rheumatol. 2007 Jun;13(3):128-33. Erratum in: J Clin Rheumatol. 2007 Oct;13(5):302.

PMID:
17551377
11.
12.

Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group.

Alarcón GS, McGwin G Jr, Bastian HM, Roseman J, Lisse J, Fessler BJ, Friedman AW, Reveille JD.

Arthritis Rheum. 2001 Apr;45(2):191-202. Erratum in: Arthritis Rheum 2001 Jun;45(3):306.

14.

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.

Fernández M, Calvo-Alén J, Alarcón GS, Roseman JM, Bastian HM, Fessler BJ, McGwin G Jr, Vilá LM, Sanchez ML, Reveille JD.

Arthritis Rheum. 2005 Jun;52(6):1655-64.

15.

Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D.

Sanchez ML, McGwin G Jr, Durán S, Fernández M, Reveille JD, Vilá LM, Alarcón GS; LUMINA Study Group.

Clin Exp Rheumatol. 2009 Jan-Feb;27(1):67-71.

PMID:
19327231
16.

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patients.

Calvo-Alén J, Toloza SM, Fernández M, Bastian HM, Fessler BJ, Roseman JM, McGwin G Jr, Vilá LM, Reveille JD, Alarcón GS; LUMINA Study Group.

Arthritis Rheum. 2005 Jul;52(7):2060-8.

17.

Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity.

Alarcón GS, McGwin G Jr, Sanchez ML, Bastian HM, Fessler BJ, Friedman AW, Baethge BA, Roseman J, Reveille JD.

Arthritis Rheum. 2004 Feb 15;51(1):73-7.

18.

Systemic lupus erythematosus in a multiethnic U.S. cohort (LUMINA) XXVII: factors predictive of a decline to low levels of disease activity.

Bertoli AM, Alarcón GS, McGwin G Jr, Fernández M, Bastian HM, Fessler BJ, Vilá LM, Reveille JD; LUMINA Study Group.

Lupus. 2006;15(1):13-8.

PMID:
16482740
19.

Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability.

Bertoli AM, Fernández M, Alarcón GS, Vilá LM, Reveille JD.

Ann Rheum Dis. 2007 Jan;66(1):12-7. Epub 2006 Jun 30.

20.

Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.

Pons-Estel GJ, Alarcón GS, González LA, Zhang J, Vilá LM, Reveille JD, McGwin G Jr; Lumina Study Group.

Arthritis Care Res (Hoboken). 2010 Mar;62(3):393-400. doi: 10.1002/acr.20097.

Items per page

Supplemental Content

Write to the Help Desk